Effectiveness of Atorvastatin for Reducing Low-Density Lipoprotein Cholesterol to National Cholesterol Education Program Treatment Goals

Reduction of LDL Cholesterol by 25% to 60% in Patients With Primary Hypercholesterolemia by Atorvastatin, a New HMG-CoA Reductase Inhibitor

1995 • 474 citations

National cholesterol education program: Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II)

1994 • 469 citations

Efficacy and Safety of a New HMG-CoA Reductase Inhibitor, Atorvastatin, in Patients With Hypertriglyceridemia

1996 • 394 citations

Task force 1. Pathogenesis of coronary disease: The biologic role of risk factors

1996 • 190 citations

Inadequate treatment with HMG-CoA reductase inhibitors by health care providers

1996 • 175 citations

Task force 4. Efficacy of risk factor management

1996 • 49 citations